<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02444026</url>
  </required_header>
  <id_info>
    <org_study_id>M-2012-553-12</org_study_id>
    <nct_id>NCT02444026</nct_id>
  </id_info>
  <brief_title>Feasibility and Efficacy of Internet-delivered CBT for Insomnia in a National Cohort of Danish Breast Cancer Survivors</brief_title>
  <official_title>Feasibility and Efficacy of an Internet-delivered Cognitive-behavioral Intervention for Insomnia in a National Cohort of Danish Breast Cancer Survivors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Danish Breast Cancer Cooperative Group</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim is, in a randomized controlled trial, to test the feasibility and evaluate the
      efficacy of an internet-based treatment for insomnia, previously tested in a group of 28 US
      cancer patients, in a large sample of Danish breast cancer survivors who are experiencing
      significant sleep problems 0-3 years after treatment. The investigators aim to test the
      following hypotheses: That a group receiving Internet-delivered cognitive-behavioral therapy
      (CCBT) for insomnia (CCBT-I) will experience reduced sleep latency, more hours of sleep,
      fewer awakenings during the night, improved sleep efficiency, increased subjective sleep
      quality, and improved quality of life after the intervention, when compared to a waiting list
      control group. The investigators also aim to explore a number of possible moderators of the
      effect (comorbidity, depression, fear of cancer recurrence tendency to ruminate) and
      mediating mechanisms (changes in sleep habits and sleep-related lifestyle factors).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      METHODS PARTICIPANTS

      The participants are able, legally competent women, 18 years or older, from a national cohort
      of Danish women treated for primary breast cancer between 1st of June 2011 and 1st of Juli
      2014:

      Inclusion criteria: 1) Reported moderate-to-severe sleep disturbances, defined as a score&gt; 5
      on the Pittsburgh Sleep Quality Index (PSQI) (32;33) (see below), and 2) are found to be
      disease free. Furthermore, participants 3) are required to have access to the Internet.

      Exclusion criteria: 1) Recurrence of breast cancer, 2) a second cancer, 3) and other serious
      physical or psychological comorbidity (e.g. depression, cardiovascular disease, and COPD), 4)
      shift work schedule, 5) other sleep disorders (sleep apnea, narcolepsy).

      PROCEDURE INFORMATION AND REQUEST TO PARTICIPATE Women who fulfill the inclusion criteria and
      indicate an interest in receiving further information receive an information folder by post
      informing.

      BASELINE MEASURES:

      The baseline questionnaires contains questions about sleep quality, fatigue, depression,
      anxiety, quality of life, sleep habits and sleep-relevant lifestyles, together with use of
      health care services, sleep medication, and use of alternative medicine with the aim of
      treating sleep problems.

      INTERVENTION:

      The intervention program is designed to be completed in 6 weeks. To ensure that all
      participants have opportunity to complete the program they are granted access to the program
      for nine weeks .

      POST-INTERVENTION:

      After the intervention, participants in both groups are asked to complete a post-intervention
      questionnaire package and then to fill in the sleep diary for a 2-week period.

      FOLLOW-UP:

      After an additional 4 weeks both groups complete two sleep questionnaires (PSQI and the
      insomnia severity index) after which the waiting list group is offered the intervention.

      INTERVENTION The Internet intervention offered is the SHUT-i program (Sleep Healthy Using The
      Internet), which is based on the existing consensus concerning non-pharmacological treatment
      of insomnia and builds on previous validated CBT's for insomnia (CBT -I) (34).

      CONTROL GROUP Participants randomly assigned to the control condition are told that for
      practical reasons, they have to wait 15 weeks before partaking in the intervention.

      PRIMARY ENDPOINTS A) Sleep diary (bedtime, sleep onset latency (SOL), number of awakenings,
      total length of awakenings, wake time, arising time, daytime naps, rating of soundness of
      previous night's sleep, rating of refreshed feeling upon morning awakening, and information
      about sleep aids : medication and/or alcohol use).

      B) The Pittsburgh Sleep Quality Index (PSQI) (33). C) The Insomnia Severity Index (ISI) (39).

      NUMBER OF PARTICIPANTS The combined effects found in the meta-analysis of published
      randomized trials of Internet-based treatment for insomnia (30) are: sleep quality (d=0.41),
      sleep efficiency (d=0.40), number of awakenings (d=-0.45), sleep onset latency (d=-0.55),
      total minutes slept (d=.22), time spent in bed (d=.25). If the investigators aim to detect an
      effect corresponding to an average of the effects above (d = 0.38) with 80% statistical
      power, at least 2 x 109 participants are required.

      ETHICAL CONSIDERATIONS The investigators will adhere to the general ethical guidelines for
      human trials. All participants receive oral and written information about the project. They
      are informed that they can withdraw at any time from the study with no consequence for their
      current or future treatment. Participants are advised to continue any medical treatment for
      insomnia, and to consult a doctor before changing medical regimen.

      PRIVACY AND DATA SECURITY The SHUT-I program stores any personal information in a separate
      one-way system that cannot be accessed from the Internet but only locally by the SHUT-i
      administrators. Connections between personal information and other data are encrypted. Data
      is stored physically on servers in locked facilities, in the United States.

      ADVERSE EFFECTS, INCONVENIENCES, BENEFITS, AND RISKS The investigators do not expect
      Internet-based cognitive behavioral therapy to be associated with any adverse health effects
      or risks as no adverse effects has been reported for conventional CBT for insomnia.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2014</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">July 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sleep diary</measure>
    <time_frame>Up to 7 month</time_frame>
    <description>The online sleep diaries contains 10 standard questions including information about bedtime, sleep onset latency (SOL), number of awakenings, total length of awakenings, wake time, arising time, daytime naps, rating of soundness of previous night's sleep, rating of refreshed feeling upon morning awakening, and information about sleep aids (medication and/or alcohol use).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The Pittsburgh Sleep Quality Index</measure>
    <time_frame>Up to 7 month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>The Insomnia Severity Index</measure>
    <time_frame>Up to 7 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional Assessment of Chronic Illness Therapy (FACIT)</measure>
    <time_frame>Up to 7 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck's Depression Inventory (BDI-II)</measure>
    <time_frame>Up to 7 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>State-Trait Anxiety Inventory (STAI)</measure>
    <time_frame>Up to 7 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EQ-5D</measure>
    <time_frame>Up to 7 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-12</measure>
    <time_frame>Up to 7 month</time_frame>
    <description>Quality of life (QoL) is measured with the SF-12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive Failures Questionnaire (CFQ)</measure>
    <time_frame>Up to 7 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep habits and sleep-relevant lifestyle</measure>
    <time_frame>Up to 7 month</time_frame>
    <description>Is assessed by adapting, further developing, and testing in the first phase of the study an existing instrument (Suzuki E, Tsuchiya M, Hirokawa K, Taniguchi T, Mitsuhashi T, Kawakami N. Evaluation of an internet-based self-help program for better quality of sleep among Japanese workers: a randomized controlled trial. J Occup Health 2008;50(5):387-99.), that measures: activities before bedtime, eating habits before bedtime, use of stimulants (coffee, tea, cola), alcohol, activities in the bedroom, exercise, thought patterns concerning sleep, etc.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of health services, self-help methods, sleep medication,fatigue, morningness-eveningness type, and complementary and alternative medicine/treatment</measure>
    <time_frame>Up to 7 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain (questionnaire)</measure>
    <time_frame>Up to 7 month</time_frame>
    <description>A short questionnaire assessing pain is included</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Moderator - Fear of Cancer Recurrence (FCR)</measure>
    <time_frame>Up to 7 month</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Moderator - Depressive symptoms (BDI-II)</measure>
    <time_frame>Up to 7 month</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Moderator - Charlson comorbidity index</measure>
    <time_frame>Up to 7 month</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Moderator -Emotional Control Scale (ECQ-R)</measure>
    <time_frame>Up to 7 month</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Moderator - The expected effects of and motivation to complete the intervention</measure>
    <time_frame>Up to 7 month</time_frame>
    <description>A short questionnaire has been developed to assess the expected effects of and motivation to complete the intervention</description>
  </other_outcome>
  <other_outcome>
    <measure>Moderator - Use of health services, self-help methods, sleep medication, and complementary and alternative medicine/treatment</measure>
    <time_frame>Up to 7 month</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Moderator - Pain</measure>
    <time_frame>Up to 7 month</time_frame>
    <description>A short questionnaire assessing pain has been developed</description>
  </other_outcome>
  <other_outcome>
    <measure>Moderator - Subjective response to a specific traumatic event</measure>
    <time_frame>Up to 7 month</time_frame>
    <description>The impact of event scale-revised (Weiss, D.S. The Impact of Event Scale-Revised. In J.P. Wilson, &amp; T.M. Keane (Eds.), Assessing psychological trauma and PTSD: A practitioner'shandbook (2nd ed., pp. 168-189).2004. New York: Guilford Press
) is included as a measure of subjective response to a specific traumatic event. This scale approximates the DSM-IV criteria for posttraumatic stress disorder. Subjective response to both breast cancer and one other self-chosen traumatic event is assessed. The delineation of the self-chosen traumatic event is based on the traumatic life event questionnaire (TLEQ)</description>
  </other_outcome>
  <other_outcome>
    <measure>Moderator - Traumatic Life Events Questionnaire (TLEQ)</measure>
    <time_frame>Up to 7 month</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Mediator - Changes in sleep habits and sleep-related lifestyle from baseline to post-intervention</measure>
    <time_frame>Up to 7 month</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Mediator - The experience of and satisfaction with the intervention</measure>
    <time_frame>Up to 7 month</time_frame>
    <description>Weiss, D.S. The Impact of Event Scale-Revised. In J.P. Wilson, &amp; T.M. Keane (Eds.), Assessing psychological trauma and PTSD: A practitioner'shandbook (2nd ed., pp. 168-189).2004. New York: Guilford Press Weiss, D.S. The Impact of Event Scale-Revised. In J.P. Wilson, &amp; T.M. Keane (Eds.), Assessing psychological trauma and PTSD: A practitioner'shandbook (2nd ed., pp. 168-189).2004. New York: Guilford Press Measured by the instrument developed in the first trials of the SHUTi intervention (Thorndike FP, Saylor DK, Bailey ET, Gonder-Frederick L, Morin CM, Ritterband LM. Develop- ment and Perceived Utility and Impact of an Internet Intervention for Insomnia. E J Appl Psychol 2008;4(2):32-42.
)</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">225</enrollment>
  <condition>Insomnia</condition>
  <arm_group>
    <arm_group_label>iCBT for Insomnia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The Internet intervention offered is the SHUT-i program (Sleep Healthy Using The Internet), which is based on the existing consensus concerning non-pharmacological treatment of insomnia and builds on previous validated CBT's for insomnia (CBT -I)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The control group will be offered the intervention AFTER the study</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>iCBT for Insomnia</intervention_name>
    <description>Internet-delivered Cognitive Behavioural Therapy for Insomnia</description>
    <arm_group_label>iCBT for Insomnia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Reported moderate-to-severe sleep disturbances, defined as a score&gt; 5 on the
             Pittsburgh Sleep Quality Index (PSQI).

          -  Disease free.

          -  Access to the Internet.

        Exclusion Criteria:

          -  Recurrence of breast cancer

          -  A second cancer

          -  Other serious physical or psychological comorbidity (e.g. depression, cardiovascular
             disease, and COPD)

          -  Night work schedule

          -  Other sleep disorders (sleep apnea, narcolepsy) .
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Zachariae, MDSci</last_name>
    <role>Study Director</role>
    <affiliation>Unit for Psychooncology and Health Psychology Dept. of Oncology, Aarhus University Hospital and Dept of Psychology and Behavioural Science, Aarhus University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Robert Zachariae, MDSci</last_name>
    <phone>+45 871 65878</phone>
    <email>bzach@aarhus.rm.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jesper Dahlgaard, PhD</last_name>
    <phone>+45 8716 5494 / +45 23254157</phone>
    <email>jesper@psy.au.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Unit for Psychooncology and Health Psychology, Dept. of Oncology, Aarhus University Hospital and Dept of Psychology and Behavioural Science, Aarhus University</name>
      <address>
        <city>Aarhus</city>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Zachariae, DMSci</last_name>
      <phone>+45 871 65878</phone>
      <email>bzach@aarhus.rm.dk</email>
    </contact>
    <contact_backup>
      <last_name>Jesper Dahlgaard, PhD</last_name>
      <phone>+45 8716 5494 / +45 23254157</phone>
      <email>jesper@psy.au.dk</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <reference>
    <citation>American Psychiatric Asssociation. Diagnostic and Statistical Manual of Mental Disor ders. Washington, DC: American Psychiatric Association; 2000.</citation>
  </reference>
  <reference>
    <citation>Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002 Apr;6(2):97-111.</citation>
    <PMID>12531146</PMID>
  </reference>
  <reference>
    <citation>Buysse DJ. Insomnia state of the science: an evolutionary, evidence-based assessment. Sleep. 2005 Sep;28(9):1045-6.</citation>
    <PMID>16268371</PMID>
  </reference>
  <reference>
    <citation>Roth T. Insomnia: definition, prevalence, etiology, and consequences. J Clin Sleep Med. 2007 Aug 15;3(5 Suppl):S7-10. Review.</citation>
    <PMID>17824495</PMID>
  </reference>
  <reference>
    <citation>Fiorentino L, Ancoli-Israel S. Sleep dysfunction in patients with cancer. Curr Treat Options Neurol. 2007 Sep;9(5):337-46.</citation>
    <PMID>17716597</PMID>
  </reference>
  <reference>
    <citation>Savard J, Ivers H, Villa J, Caplette-Gingras A, Morin CM. Natural course of insomnia comorbid with cancer: an 18-month longitudinal study. J Clin Oncol. 2011 Sep 10;29(26):3580-6. doi: 10.1200/JCO.2010.33.2247. Epub 2011 Aug 8.</citation>
    <PMID>21825267</PMID>
  </reference>
  <reference>
    <citation>Price MA, Zachariae R, Butow PN, deFazio A, Chauhan D, Espie CA, Friedlander M, Webb PM; Australian Ovarian Cancer Study Group; Australian Ovarian Cancer Study - Quality of Life Study Investigators. Prevalence and predictors of insomnia in women with invasive ovarian cancer: anxiety a major factor. Eur J Cancer. 2009 Dec;45(18):3262-70. doi: 10.1016/j.ejca.2009.05.030. Epub 2009 Jun 18.</citation>
    <PMID>19540748</PMID>
  </reference>
  <reference>
    <citation>Colagiuri B, Christensen S, Jensen AB, Price MA, Butow PN, Zachariae R. Prevalence and predictors of sleep difficulty in a national cohort of women with primary breast cancer three to four months postsurgery. J Pain Symptom Manage. 2011 Nov;42(5):710-20. doi: 10.1016/j.jpainsymman.2011.02.012. Epub 2011 May 26.</citation>
    <PMID>21620648</PMID>
  </reference>
  <reference>
    <citation>Hall M, Baum A, Buysse DJ, Prigerson HG, Kupfer DJ, Reynolds CF 3rd. Sleep as a mediator of the stress-immune relationship. Psychosom Med. 1998 Jan-Feb;60(1):48-51.</citation>
    <PMID>9492239</PMID>
  </reference>
  <reference>
    <citation>Irwin M. Effects of sleep and sleep loss on immunity and cytokines. Brain Behav Immun. 2002 Oct;16(5):503-12. Review.</citation>
    <PMID>12401464</PMID>
  </reference>
  <reference>
    <citation>Baron KG, Reid KJ, Kern AS, Zee PC. Role of sleep timing in caloric intake and BMI. Obesity (Silver Spring). 2011 Jul;19(7):1374-81. doi: 10.1038/oby.2011.100. Epub 2011 Apr 28.</citation>
    <PMID>21527892</PMID>
  </reference>
  <reference>
    <citation>Hairston KG, Bryer-Ash M, Norris JM, Haffner S, Bowden DW, Wagenknecht LE. Sleep duration and five-year abdominal fat accumulation in a minority cohort: the IRAS family study. Sleep. 2010 Mar;33(3):289-95.</citation>
    <PMID>20337186</PMID>
  </reference>
  <reference>
    <citation>Vgontzas AN, Bixler EO. Short sleep and obesity: are poor sleep, chronic stress, and unhealthy behaviors the link? Sleep. 2008 Sep;31(9):1203.</citation>
    <PMID>18788643</PMID>
  </reference>
  <reference>
    <citation>Cappuccio FP, D'Elia L, Strazzullo P, Miller MA. Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Sleep. 2010 May;33(5):585-92. Review.</citation>
    <PMID>20469800</PMID>
  </reference>
  <reference>
    <citation>Dew MA, Hoch CC, Buysse DJ, Monk TH, Begley AE, Houck PR, Hall M, Kupfer DJ, Reynolds CF 3rd. Healthy older adults' sleep predicts all-cause mortality at 4 to 19 years of follow-up. Psychosom Med. 2003 Jan-Feb;65(1):63-73. Erratum in: Psychosom Med. 2003 Mar-Apr;65(2):210.</citation>
    <PMID>12554816</PMID>
  </reference>
  <reference>
    <citation>Sleep complaints: Whenever possible, avoid the use of sleeping pills. Prescrire Int. 2008 Oct;17(97):206-12.</citation>
    <PMID>19536941</PMID>
  </reference>
  <reference>
    <citation>Belleville G. Mortality hazard associated with anxiolytic and hypnotic drug use in the National Population Health Survey. Can J Psychiatry. 2010 Sep;55(9):558-67.</citation>
    <PMID>20840803</PMID>
  </reference>
  <reference>
    <citation>Moore TA, Berger AM, Dizona P. Sleep aid use during and following breast cancer adjuvant chemotherapy. Psychooncology. 2011 Mar;20(3):321-5. doi: 10.1002/pon.1756.</citation>
    <PMID>20878849</PMID>
  </reference>
  <reference>
    <citation>van Straten A, Cuijpers P. Self-help therapy for insomnia: a meta-analysis. Sleep Med Rev. 2009 Feb;13(1):61-71. doi: 10.1016/j.smrv.2008.04.006. Epub 2008 Oct 26.</citation>
    <PMID>18952469</PMID>
  </reference>
  <reference>
    <citation>de Niet G, Tiemens B, Lendemeijer B, Hutschemaekers G. Music-assisted relaxation to improve sleep quality: meta-analysis. J Adv Nurs. 2009 Jul;65(7):1356-64. doi: 10.1111/j.1365-2648.2009.04982.x. Epub 2009 Apr 28. Review.</citation>
    <PMID>19456998</PMID>
  </reference>
  <reference>
    <citation>Irwin MR, Cole JC, Nicassio PM. Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in middle-aged adults and in older adults 55+ years of age. Health Psychol. 2006 Jan;25(1):3-14. Review.</citation>
    <PMID>16448292</PMID>
  </reference>
  <reference>
    <citation>Smith MT, Perlis ML, Park A, Smith MS, Pennington J, Giles DE, Buysse DJ. Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry. 2002 Jan;159(1):5-11.</citation>
    <PMID>11772681</PMID>
  </reference>
  <reference>
    <citation>Morin CM, Culbert JP, Schwartz SM. Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy. Am J Psychiatry. 1994 Aug;151(8):1172-80.</citation>
    <PMID>8037252</PMID>
  </reference>
  <reference>
    <citation>Ritterband LM, Bailey ET, Thorndike FP, Lord HR, Farrell-Carnahan L, Baum LD. Psychooncology 2011 Apr 29.</citation>
  </reference>
  <reference>
    <citation>Ritterband LM, Thorndike FP, Gonder-Frederick LA, Magee JC, Bailey ET, Saylor DK, Morin CM. Efficacy of an Internet-based behavioral intervention for adults with insomnia. Arch Gen Psychiatry. 2009 Jul;66(7):692-8. doi: 10.1001/archgenpsychiatry.2009.66. Erratum in: Arch Gen Psychiatry. 2010 Mar;67(3):311.</citation>
    <PMID>19581560</PMID>
  </reference>
  <reference>
    <citation>Vincent N, Lewycky S. Logging on for better sleep: RCT of the effectiveness of online treatment for insomnia. Sleep. 2009 Jun;32(6):807-15.</citation>
    <PMID>19544758</PMID>
  </reference>
  <reference>
    <citation>Suzuki E, Tsuchiya M, Hirokawa K, Taniguchi T, Mitsuhashi T, Kawakami N. Evaluation of an internet-based self-help program for better quality of sleep among Japanese workers: a randomized controlled trial. J Occup Health. 2008;50(5):387-99. Epub 2008 Aug 19.</citation>
    <PMID>18716392</PMID>
  </reference>
  <reference>
    <citation>Ström L, Pettersson R, Andersson G. Internet-based treatment for insomnia: a controlled evaluation. J Consult Clin Psychol. 2004 Feb;72(1):113-20.</citation>
    <PMID>14756620</PMID>
  </reference>
  <reference>
    <citation>Riley WT, Mihm P, Behar A, Morin CM. A computer device to deliver behavioral interventions for insomnia. Behav Sleep Med. 2010;8(1):2-15. doi: 10.1080/15402000903425314.</citation>
    <PMID>20043245</PMID>
  </reference>
  <reference>
    <citation>Cheng SK, Dizon J. Computerised cognitive behavioural therapy for insomnia: a systematic review and meta-analysis. Psychother Psychosom. 2012;81(4):206-16. doi: 10.1159/000335379. Epub 2012 May 11. Review.</citation>
    <PMID>22585048</PMID>
  </reference>
  <reference>
    <citation>Espie CA, Kyle SD, Williams C, Ong JC, Douglas NJ, Hames P, Brown JS. A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep. 2012 Jun 1;35(6):769-81. doi: 10.5665/sleep.1872.</citation>
    <PMID>22654196</PMID>
  </reference>
  <reference>
    <citation>Beck SL, Schwartz AL, Towsley G, Dudley W, Barsevick A. Psychometric evaluation of the Pittsburgh Sleep Quality Index in cancer patients. J Pain Symptom Manage. 2004 Feb;27(2):140-8.</citation>
    <PMID>15157038</PMID>
  </reference>
  <reference>
    <citation>Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193-213.</citation>
    <PMID>2748771</PMID>
  </reference>
  <reference>
    <citation>NIH State-of-the-Science Conference Statement on manifestations and management of chronic insomnia in adults. NIH Consens State Sci Statements. 2005 Jun 13-15;22(2):1-30. Review.</citation>
    <PMID>17308547</PMID>
  </reference>
  <reference>
    <citation>Thorndike FP, Saylor DK, Bailey ET, Gonder-Frederick L, Morin CM, Ritterband LM. Development and Perceived Utility and Impact of an Internet Intervention for Insomnia. E J Appl Psychol. 2008;4(2):32-42.</citation>
    <PMID>20953264</PMID>
  </reference>
  <reference>
    <citation>Buysse DJ, Ancoli-Israel S, Edinger JD, Lichstein KL, Morin CM. Recommendations for a standard research assessment of insomnia. Sleep. 2006 Sep;29(9):1155-73. Review. Erratum in: Sleep. 2006 Nov 1;29(11):1380.</citation>
    <PMID>17040003</PMID>
  </reference>
  <reference>
    <citation>Backhaus J, Junghanns K, Broocks A, Riemann D, Hohagen F. Test-retest reliability and validity of the Pittsburgh Sleep Quality Index in primary insomnia. J Psychosom Res. 2002 Sep;53(3):737-40.</citation>
    <PMID>12217446</PMID>
  </reference>
  <reference>
    <citation>Thomsen DK, Mehlsen MY, Christensen S, Zachariae Rt. Pers Individ Diff 2003;34:1293-301.</citation>
  </reference>
  <reference>
    <citation>Morin CM. Insomnia: psychological assessment and management. New York: Guilford Press; 1993.</citation>
  </reference>
  <reference>
    <citation>Bastien CH, Vallières A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001 Jul;2(4):297-307.</citation>
    <PMID>11438246</PMID>
  </reference>
  <reference>
    <citation>Thorndike FP, Ritterband LM, Saylor DK, Magee JC, Gonder-Frederick LA, Morin CM. Validation of the insomnia severity index as a web-based measure. Behav Sleep Med. 2011;9(4):216-23. doi: 10.1080/15402002.2011.606766.</citation>
    <PMID>22003975</PMID>
  </reference>
  <reference>
    <citation>Savard MH, Savard J, Simard S, Ivers H. Empirical validation of the Insomnia Severity Index in cancer patients. Psychooncology. 2005 Jun;14(6):429-41.</citation>
    <PMID>15376284</PMID>
  </reference>
  <reference>
    <citation>Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage. 1997 Feb;13(2):63-74.</citation>
    <PMID>9095563</PMID>
  </reference>
  <reference>
    <citation>Beck AT, Steer RA, Brown GK. Manual: Beck Depression Inventory. 2 ed. San Antonio, TX: The Psychological Corporation. Hartcourt &amp; Brace.; 1996.</citation>
  </reference>
  <reference>
    <citation>Christensen S, Zachariae R, Jensen AB, Vaeth M, Møller S, Ravnsbaek J, von der Maase H. Prevalence and risk of depressive symptoms 3-4 months post-surgery in a nationwide cohort study of Danish women treated for early stage breast-cancer. Breast Cancer Res Treat. 2009 Jan;113(2):339-55. doi: 10.1007/s10549-008-9920-9. Epub 2008 Feb 16.</citation>
    <PMID>18278553</PMID>
  </reference>
  <reference>
    <citation>Spielberger CD. Psychological Assessment Resources Odessa FA 1988 1988.</citation>
  </reference>
  <reference>
    <citation>Zachariae R, Melchiorsen H, Frøbert O, Bjerring P, Bagger JP. Experimental pain and psychologic status of patients with chest pain with normal coronary arteries or ischemic heart disease. Am Heart J. 2001 Jul;142(1):63-71.</citation>
    <PMID>11431658</PMID>
  </reference>
  <reference>
    <citation>Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, Bullinger M, Kaasa S, Leplege A, Prieto L, Sullivan M. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol. 1998 Nov;51(11):1171-8.</citation>
    <PMID>9817135</PMID>
  </reference>
  <reference>
    <citation>Bjørner JB, Damsgaard MT, Watt T, Bech P, Rasmussen NK, Kristensen TS, et al. Copenhagen: Lif; 1997.</citation>
  </reference>
  <reference>
    <citation>Broadbent DE, Cooper PF, FitzGerald P, Parkes KR. The Cognitive Failures Questionnaire (CFQ) and its correlates. Br J Clin Psychol. 1982 Feb;21 (Pt 1):1-16.</citation>
    <PMID>7126941</PMID>
  </reference>
  <reference>
    <citation>Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW. Can comorbidity be measured by questionnaire rather than medical record review? Med Care. 1996 Jan;34(1):73-84.</citation>
    <PMID>8551813</PMID>
  </reference>
  <reference>
    <citation>Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994 Nov;47(11):1245-51.</citation>
    <PMID>7722560</PMID>
  </reference>
  <reference>
    <citation>Roger D, Najarian B. Pers Indiv Diff 1989;10(8):845-53.</citation>
  </reference>
  <reference>
    <citation>Weiss, D.S. The Impact of Event Scale-Revised. In J.P. Wilson, &amp; T.M. Keane (Eds.), Assessing psychological trauma and PTSD: A practitioner'shandbook (2nd ed., pp. 168-189).2004. New York: Guilford Press.</citation>
  </reference>
  <reference>
    <citation>Kubany ES, Haynes SN, Leisen MB, Owens JA, Kaplan AS, Watson SB, Burns K. Development and preliminary validation of a brief broad-spectrum measure of trauma exposure: the Traumatic Life Events Questionnaire. Psychol Assess. 2000 Jun;12(2):210-24.</citation>
    <PMID>10887767</PMID>
  </reference>
  <reference>
    <citation>O'Connor M, Christensen S, Jensen AB, Møller S, Zachariae R. How traumatic is breast cancer? Post-traumatic stress symptoms (PTSS) and risk factors for severe PTSS at 3 and 15 months after surgery in a nationwide cohort of Danish women treated for primary breast cancer. Br J Cancer. 2011 Feb 1;104(3):419-26. doi: 10.1038/sj.bjc.6606073. Epub 2011 Jan 11.</citation>
    <PMID>21224851</PMID>
  </reference>
  <reference>
    <citation>Pedersen CG, Christensen S, Jensen AB, Zachariae R. Prevalence, socio-demographic and clinical predictors of post-diagnostic utilisation of different types of complementary and alternative medicine (CAM) in a nationwide cohort of Danish women treated for primary breast cancer. Eur J Cancer. 2009 Dec;45(18):3172-81. doi: 10.1016/j.ejca.2009.09.005. Epub 2009 Oct 5.</citation>
    <PMID>19811905</PMID>
  </reference>
  <reference>
    <citation>Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986 Dec;51(6):1173-82.</citation>
    <PMID>3806354</PMID>
  </reference>
  <reference>
    <citation>Kenny DA, Kashy DA, Bolger N. Data analysis in social psychology. In: Gilbert D, Fiske S,Lindzey G, editors. The handbook of social psychology. 4 ed. Boston,MA: McGraw-Hill; 1998. p. 233-65.</citation>
  </reference>
  <reference>
    <citation>MacKinnon DP, Lockwood CM, Hoffman JM, West SG, Sheets V. A comparison of methods to test mediation and other intervening variable effects. Psychol Methods. 2002 Mar;7(1):83-104.</citation>
    <PMID>11928892</PMID>
  </reference>
  <reference>
    <citation>Sobel ME. Asymptotic intervals for indirect effects in structural equation models. In: Leinhart S, editor. Sociological methodology.San Francisco: Jossey-Bass; 1982. p. 290-312.</citation>
  </reference>
  <reference>
    <citation>Muller D, Judd CM, Yzerbyt VY. When moderation is mediated and mediation is moderated. J Pers Soc Psychol. 2005 Dec;89(6):852-63.</citation>
    <PMID>16393020</PMID>
  </reference>
  <reference>
    <citation>Danmarks Statistik (Statistics Denmark). Befolkningens brug af internet (Internet use in the Danish population). Copenhagen: Danmarks Statistik (Statistics Denmark); 2011.</citation>
  </reference>
  <reference>
    <citation>Jensen-Johansen M, Christensen S, Valdimarsdottir H, Zakowski S, Bovbjerg DH, Jensen AB, et al. Unpublished manuscript 2010.</citation>
  </reference>
  <reference>
    <citation>Uniform requirements for manuscripts submitted to biomedical journals. International Committee of Medical Journal Editors. Ann Intern Med. 1997 Jan 1;126(1):36-47.</citation>
    <PMID>8992922</PMID>
  </reference>
  <reference>
    <citation>Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010 Mar 23;340:c869. doi: 10.1136/bmj.c869.</citation>
    <PMID>20332511</PMID>
  </reference>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 10, 2014</study_first_submitted>
  <study_first_submitted_qc>May 13, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 14, 2015</study_first_posted>
  <last_update_submitted>May 13, 2015</last_update_submitted>
  <last_update_submitted_qc>May 13, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 14, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

